Ascending Multiple Intravenous Doses of AON-D21 in Healthy Male Subjects.
NCT05343819
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
AON-D21
DRUG:
Placebo
Sponsor
Aptarion Biotech AG